Desvenlafaxine 63304-0192-30
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 5, 2013
- Listing Expires
- December 31, 2026
- Application
- NDA204150
Need to source Desvenlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine | 100 mg/1 |
Drug Class
Serotonin and Norepinephrine Reuptake Inhibitor [EPC]Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]
Selected Package
63304-0192-30Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-30)
Other packages for this product(1)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-90)